NasdaqCM - Nasdaq Real Time Price USD

EUDA Health Holdings Limited (EUDA)

13.51 -1.52 (-10.11%)

At close: November 6 at 4:00:01 PM EST

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

GlobeNewswire 5mo ago

EUDA
-9.92%
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

GlobeNewswire 5mo ago

EUDA
-9.92%
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

GlobeNewswire 6mo ago

EUDA
-9.92%
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

GlobeNewswire 6mo ago

EUDA
-9.92%
Top Midday Gainers

PREMIUM
MT Newswires 10mo ago

USAU

EUDA
-9.92%
HYMC
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

GlobeNewswire 2mo ago

EUDA
-9.92%
EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

GlobeNewswire 3mo ago

EUDA
-9.92%
EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies

GlobeNewswire 3mo ago

EUDA
-9.92%
EUDA Health price target lowered to $2.75 from $6 at Greenridge

TipRanks 7mo ago

EUDA
-9.92%
EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

GlobeNewswire 10mo ago

EUDA
-9.92%
EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen

GlobeNewswire 10mo ago

EUDA
-9.92%
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement

GlobeNewswire 10mo ago

EUDA
-9.92%
CING

DMNIF

Performance Overview

Return	EUDA	S&P 500 (^GSPC)
YTD	-70.76%	+7.76%
1-Year	-77.63%	+9.77%
3-Year	-51.40%	+68.96%

U.S. markets closed

EUDA Health Holdings Limited (EUDA)

EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask

EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency

EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development

EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities

Top Midday Gainers

EUDA Health Subsidiary Melana International Wins SME100 Awards 2026 Singapore

EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness • Targets global distribution for innovative Oncology products

EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Therapies

EUDA Health price target lowered to $2.75 from $6 at Greenridge

EUDA Launches Nationwide Stem Cell Extraction, Cryostorage and Clinical Delivery Platform in China with Shenzhen Inno Immune and Wuhan Kaien Hospital

EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen

EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement